Jeffrey Yang

4PUBLICATIONS
6CO-AUTHORS
Structural properties of condensed matterCheminformatics and quantitative structure-activity relationshipsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 04, 2024
Structure-activity relationships and pharmacokinetic evaluation of L-cystine diamides as L-cystine crystallization inhibitors for cystinuria.

Longqin Hu, Haifa Albanyan, Jeffrey Yang

|Sep 08, 2023
Development of convenient crystallization inhibition assays for structure-activity relationship studies in the discovery of crystallization inhibitors.

Jeffrey Yang, Haifa Albanyan, Yiling Wang

|Sep 06, 2022
Discovery of mobocertinib, a new irreversible tyrosine kinase inhibitor indicated for the treatment of non-small-cell lung cancer harboring EGFR exon 20 insertion mutations.

Jun Wang, Daniel Lam, Jeffrey Yang

|Sep 15, 2018
Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules.

Jeffrey Yang, Longqin Hu

Pageof 1

Frequent Collaborators

4 joint publications

Longqin Hu

2 joint publications

Yiling Wang

2 joint publications

Amrik Sahota

1 joint publications

Jun Wang